Alx Oncology Holdings (ALXO) Other Non Operating Income (2020 - 2026)
Alx Oncology Holdings (ALXO) reported Other Non Operating Income of $188000.0 for Q1 2026, up 1809.09% on a YoY basis from $9847.6 in Q1 2025, and down 92.37% sequentially from $2.5 million in Q4 2025.
Alx Oncology Holdings (ALXO) Other Non Operating Income (2020 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 7 years of Other Non Operating Income data on file, last reported at $188000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 1809.09% year-over-year to $188000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 15647.06% YoY), and the FY2025 full-year result was $2.4 million, up 12320.0% from the prior year.
- Other Non Operating Income eased to $188000.0 in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $19.0 million in Q4 2022 to a low of -$14000.0 in Q1 2024.
- A 5-year average of $1.7 million and a median of -$1000.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 350.0% in 2022 and jumped 246400.0% in 2025, its largest moves.
- Tracing ALXO's Other Non Operating Income over 5 years: stood at $19.0 million in 2022, then plunged by 65.01% to $6.6 million in 2023, then tumbled by 100.02% to -$1000.0 in 2024, then jumped by 246400.0% to $2.5 million in 2025, then plunged by 92.37% to $188000.0 in 2026.
- Business Quant data shows ALXO's Other Non Operating Income at $188000.0 in Q1 2026, $2.5 million in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Alx Oncology Holdings | 211.40 Mn | 211.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 324,000.00 |
| Mar 31, 2023 | 95,000.00 |
| Dec 31, 2022 | 18.97 Mn |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | 2,000.00 |